top of page

2022 Syllabus Material

Printable Agenda

Friday, June 24, 2022

Yehuda Handelsman, MD


Jonathan D. Newman, MD, M

Outcomes of Participants with Diabetes in the ISCHEMIA Trials

Joshua J. Joseph, MD

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Seth S. Martin, MD

Digital Health Technology in Diabetes & Heart Disease

Jennifer B. Green, MD

Combinations of SGLT2 Inhibitors & GLP 1 Receptor Agonists: Potential Impact on the Kidney and the Heart

Robert P. Giugliano, MD

Dyslipidemia – Emerging Therapies

Laurence S. Sperling, MD

Aspirin for Primary Prevention:
Trials, Tribulations, and Trust

Robert J. Chilton, DO

Antiplatelet in the Prevention and Management of ASCVD in Diabetes

James Udelson, MD

Debate: Which is the Better Test? Nuclear Stress

Matthew J. Budoff, MD

Coronary Calcium Scoring for Risk
Stratification and Guidelines

Mikhail Kosiborod, MD

Prevention and Management of ASCVD in Diabetes

Allana A. Morris, MD

Sodium Glucose Cotransporter 2 Inhibitors in HF: Racial Differences and a Potential for Reducing Disparities

Sadiya Khan, MD

Equitably Bending the Curve: Trends and Inequities in Diabetes/CVD Outcomes

Richard Bergenstal, MD

The Role of CGM in the Wide & Narrow Spectrum of Diabetes

Robert Toto, MD

Role of Steroidal and Non
Steroidal MRA in Cardiorenal Diseases

Lawrence A. Leiter, MD

Individualized CVOT Directed Management For Our Patients with

DM and/or CardioRenal Metabolic Diseases

Kausik Ray, MD, MPhil

 LDL-C lowering and CV outcomes - Have we reached the limits yet?

Peter J. Grant, MD

The Influence of Diabetes on the Efficacy of Aspirin Therapy - Glucose Control and Acetyl Salicylic Acid

Christie M. Ballantyne, MD

Incorporating Genetic Testing and Polygenic Risk Scores in Cardiovascular Disease Risk Assessment

Norman E. Lepor, MD

CT Angiography vs Nuclear Stress
Which is the Better Test?
For What?

Janani Rangaswami, MD

The Impact of CKD on Cardiovascular Disease

Stephen Greene, MD

Contemporary Approach to the Management of CKD and Heart Failure

Saturday, June 25, 2022

Lee Goldberg, PhD

COVID-19 Outcome in Heart Transplant and Heart Failure

William T. Cefalu, MD

COVID-19 & New Onset Diabetes: Metabolic Disorders and Research Priorities

Hertzel C. Gerstein, MD

Can Type 2 Diabetes Therapies
Slow Cognitive Decline? The Evidence

George Grunberger, MD

Hypoglycemia Impact on Comorbidities: 2022 Approach To Its Management

Stefano Del Prato, MD

Contemporary Approach to Managing Diabetes – the New and the Newer

Martha Gulati, MD

Sex Differences in

Heart Failure

Prakash Deedwania, MD

Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity

Mark Goodarzi, MD

Polycystic Ovary Syndrome and
Risk of Type 2 Diabetes, Coronary
Heart Disease and Stroke

Matthew R. Weir, MD

Overview: Diabetes, Kidney and Heart Disease

Peter Rossing, MD, DMSc

Management of Diabetes and CKD – Circa 2022

Michael Snyder, MD

Big Data and Wearables for Managing Health and COVID

Pam R. Taub, MD

Prevention and Management of Stroke in Patients with Diabetes

Vivian A. Fonseca, MD

Impact of Management of
Hyperglycemia and Blood
Pressure on Cardiovascular
Autonomic Neuropathy

Richard E. Pratley, MD

Tools to Aid Individualized Treatment for T2D

Ambarish Pandey, MD

Prevalence and Prognostic Implications of Diabetic Cardiomyopathy

Javed Butler, MD

Would Device Treatment in Heart Failure Obviate the Need for Drug Therapy?

Mamatha Bhat, MD

CVD in NAFLD: Personalizing Diagnosis and Treatment Using Machine Learning

Michael Honigberg, MD

Cardiovascular and Kidney Outcomes Across the Glycemic Spectrum

Susanne B. Nicholas, MD

Pathogenesis of CKD in Diabetes

Sunday, June 26, 2022

Ildiko Lingvay, MD, MPH, MSCs

Obesity Pharmacotherapy: Present and Future

Christos S. Mantzoros, MD, PhD

Nutrition, Exercise, Sarcopenia & Central Obesity in relation to NAFLD, T2DM & CVD

Katherine Tuttle, MD

ADA and KDIGO Consensus Statement on Diabetes and CKD

Mikhail N. Kosiborod, MD

CVOT Update

Silvio E. Inzucchi, MD

Type 2 Diabetes Treatment Guidelines: The Good, the Bad and the Ugly

Erin D. Michos, MD

Sex Differences in Diabetes impact on ASCVD and HF

Deborah Clegg, PhD, RD

The Role of Diet in CVD, CKD,
and Heart Failure

Mark E. Cooper, AO, PhD

Identifying CKD Before Its Too Late

Matthew R. Weir, MD

The Approach to the Management of Anemia in CKD

Biykem Bozkurt, MD, PhD

The 2022 ACC/AHA/HFSA Heart Failure Guidelines

Gina P. Lundberg, MD

CVD in Women, Ischemia Diagnosis and Menopause Hormone Theraphy

Neha Pagidipati, MD

Management of Cardiovascular Risk Factors During Pregnancy

bottom of page